News | Coronavirus (COVID-19) | January 03, 2022

FDA Contraindicates Janssen COVID Vaccine for People With Previous Thrombosis With Thrombocytopenia 

FDA Contraindicates Janssen COVID Vaccine for People With Previous Thrombosis With Thrombocytopenia. #COVID19 #COVIDvaccine

January 3, 2022 — The U.S. Food and Drug Administration (FDA) recently revised its Janssen COVID-19 Vaccine Fact Sheets with a contraindication for any individuals with a history of thrombosis with thrombocytopenia following the Janssen COVID-19 vaccine or any other adenovirus-vectored COVID-19 vaccine.

The fact sheets now include updated information about the risk of thrombosis with thrombocytopenia syndrome (TTS) following vaccination. The updates Occurred December 14.

Cases of thrombosis with thrombocytopenia following administration of the Janssen COVID-19 vaccine have been reported in males and females 18 years of age and older. The highest reporting rate of approximately one case per 100,000 doses administered in females 30-49 years of age. Overall, the FDA said approximately 1 out of 7 cases has been fatal. 

The FDA and Centers for Disease Control and Prevention (CDC) said they continue to investigate the level of potential excess risk. The FDA said it continues to find that the known and potential benefits of the Janssen COVID-19 vaccine outweigh its known and potential risks in individuals 18 years of age and older. 

The FDA said individuals should speak to their healthcare provider to determine which COVID-19 vaccine is most appropriate for their own situation.

Access the Fact Sheet for Healthcare Providers Administering Vaccine

Access the Fact Sheet for Recipients and Caregivers

Find more COVID related cardiovascular content

 


Related Content

News | Coronavirus (COVID-19)

November 25, 2022 — A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger ...

Home November 25, 2022
Home
News | Coronavirus (COVID-19)

November 10, 2022 — Researchers at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease ...

Home November 10, 2022
Home
News | Coronavirus (COVID-19)

November 3, 2022 — In the past several years, myocarditis has been of public interest because of cases associated with ...

Home November 03, 2022
Home
News | Coronavirus (COVID-19)

November 2, 2022 — A comprehensive review and meta-analysis of published research confirm that young adults (40 years ...

Home November 02, 2022
Home
News | Coronavirus (COVID-19)

October 27, 2022 — New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart attacks ...

Home October 27, 2022
Home
News | Coronavirus (COVID-19)

October 17, 2022 — A national study suggests that risk factors for cardiovascular disease, such as age, smoking and ...

Home October 17, 2022
Home
News | Coronavirus (COVID-19)

September 26, 2022 — Kawasaki disease (KD) is the leading cause of acquired heart disease in children in developed ...

Home September 26, 2022
Home
News | Coronavirus (COVID-19)

September 7, 2022 — A new paper in European Heart Journal - Digital Health, published by Oxford University Press ...

Home September 07, 2022
Home
News | Coronavirus (COVID-19)

August 26, 2022 — COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure ...

Home August 26, 2022
Home
News | Coronavirus (COVID-19)

August 23, 2022 — In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose ...

Home August 23, 2022
Home
Subscribe Now